The Tissue Procurement Core Facility was established in 1999 to collect, prepare, and distribute high quality human tissue samples meeting the special needs of the Cancer Center researchers. An approved application and a copy of the researcher's IRB approval are required to receive tissues from the Core Facility. The Core works synergistically with the Cooperative Human Tissue Network (CHTN), and provides unique services exclusively to Cancer Center members as well as priority access to tissues over other intramural and extramural investigators. A wide variety of tissues are available from UHC and other local area hospitals. Normal, benign, and malignant tissues are obtained from surgical resections and autopsies. Matched normal adjacent tissue and tissues from different organ sites from the same donor are also available to researchers. Special emphasis is placed on the acquisition of metastatic tissues to serve Cancer Center initiatives. Tissue samples are prepared according to individual protocols and can be fresh, snap-frozen, or fixed. Sterile tissues can be obtained for the establishment of cell lines or development of xenograft models. Tissues can also be embedded, cut and mounted on slides, and stained. Quality control (QC) reviews are conducted on tissue samples by experienced surgical pathologists to verify diagnosis. Basic demographic and histopathologic data are provided with the tissue samples. A minimal, standardized processing fee is charged to investigators for the time and effort involved in collecting, processing, storing, and distributing the research samples. Chart reviews are conducted by medical residents as a special service to obtain additional clinical information when required. Patient confidentiality is strictly maintained through the use of sample code numbers. The identity of the tissue donor is maintained by the Core Facility in a secure area in the event that follow-up data or samples are requested. Long-term, monitored storage of disease-specific tissues is also available to Cancer Center members. Surveys are conducted to ensure that the core addresses the changing needs of Cancer Center researchers, and additional services such as nucleic acid isolation and development of tissue microarrays may be offered at a future date.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA043703-14
Application #
6658316
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-09-13
Project End
2003-07-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Liu, Xia; Taftaf, Rokana; Kawaguchi, Madoka et al. (2018) Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models. Cancer Discov :
Belur Nagaraj, Anil; Joseph, Peronne; Kovalenko, Olga et al. (2018) Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer. Gynecol Oncol 151:525-532
Li, Jiayang; Gresham, Kenneth S; Mamidi, Ranganath et al. (2018) Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy. Int J Cardiol 273:168-176
Enane, Francis O; Saunthararajah, Yogen; Korc, Murray (2018) Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells. Cell Death Dis 9:912
Lennon, Donald; Solchaga, Luis A; Somoza, Rodrigo A et al. (2018) Human and Rat Bone Marrow-Derived Mesenchymal Stem Cells Differ in Their Response to Fibroblast Growth Factor and Platelet-Derived Growth Factor. Tissue Eng Part A 24:1831-1843
Evans, Daniel R; Venkitachalam, Srividya; Revoredo, Leslie et al. (2018) Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer. Hum Mutat 39:1092-1101
Augestad, Knut M; Keller, Deborah S; Bakaki, Paul M et al. (2018) The impact of rectal cancer tumor height on recurrence rates and metastatic location: A competing risk analysis of a national database. Cancer Epidemiol 53:56-64
Chen, Lechuang; Feng, Zhimin; Yue, Hong et al. (2018) Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nat Commun 9:4585
Patel, Rutulkumar; Zhang, Luchang; Desai, Amar et al. (2018) Mlh1 deficiency increases the risk of hematopoietic malignancy after simulated space radiation exposure. Leukemia :
Lager, Angela M; Corradin, Olivia G; Cregg, Jared M et al. (2018) Rapid functional genetics of the oligodendrocyte lineage using pluripotent stem cells. Nat Commun 9:3708

Showing the most recent 10 out of 1227 publications